Methods of administering elagolix | Patent Number 10537572

US 10537572 B2
Application Number15957469
Publication NumberUS 20180235963 A1
Pendency1 year, 9 months, 7 days
Filled DateApr 19, 2018
Priority DateSep 1, 2015
Publication DateAug 23, 2018
Expiration DateAug 31, 2035
Inventor/ApplicantsCheri E. Klein
Ahmed Salem
Sandra L. Goss
Juki Wing-Keung Ng
ExaminesREESE, HEIDI L
Art Unit1657
Technology Center1600
Assignments
Abbvie Inc.
Current
Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.